Delivery Order SPE2DB20D2014-SPE2DB25FB92K
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,630.84 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 23, 2025, with an ultimate completion date of April 24, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical products to support federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pen injections on June 4, 2025, with an ultimate completion date of June 5, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a single transaction for pharmaceutical supply under the...
- The Defense Logistics Agency awarded a delivery order valued at $2,252.25 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. This competitively awarded, firm fixed-price delivery order is expected to be completed by August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating the contract was opened to full competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens with a ceiling value of $11,447.80 on September 26, 2025, with an ultimate completion date of September 29, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a pharmaceutical supply procurement supporting federal military and healthcare operations. The contract will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 3 mg/0.5 ml pens valued at $18,827.70. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the vendor's established capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on June 2, 2025, with a ceiling value of $1,501.50 and an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,388.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitive, non-set-aside contract operates under a firm fixed price arrangement and represents a delivery order against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Trulicity 3 mg/0.5 mL pens in 0.5 mL formulation. This firm fixed-price delivery order, valued at $3,003.00, is scheduled for completion by September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,164.26 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on September 2, 2025, with completion expected by September 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a purchase of pharmaceutical products to support federal medical supply needs within the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB92KDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,252.25 on May 12, 2025, for the supply of Trulicity 3 mg/0.5 ml pens (0.5 ml units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of May 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a discrete purchase under the federal pharmaceutical supply chain managed by DLA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has successfully competed for federal procurement through open competition and maintains significant capacity to fulfill complex medical supply requirements for the defense establishment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/12/25 |